Recordati Industria Chimica e Farmaceutica SPA (RECN) Stock Statistics & Valuation Metrics

Recordati Industria Chimica e Farmaceutica SPA has a market cap or net worth of MXN 230.25B. The enterprise value is MXN 12.60B.

Market Cap

MXN 230.25B

Enterprise Value

MXN 12.60B

Recordati Industria Chimica e Farmaceutica SPA has 209,125,150 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

209,125,150

Owned by Insiders

0.08%

Owned by Institutions

<0.01%

Recordati Industria Chimica e Farmaceutica SPA’s return on equity (ROE) is 0.23 and return on invested capital (ROIC) is 12.11%.

Return on Equity (ROE)

0.23

Return on Assets (ROA)

0.08

Return on Invested Capital (ROIC)

12.11%

Return on Capital Employed (ROCE)

0.17

Revenue Per Employee

557.93K

Profits Per Employee

94.53K

Employee Count

4,693

Asset Turnover

0.50

Inventory Turnover

1.54

The current PE Ratio of Recordati Industria Chimica e Farmaceutica SPA is 21.81. Recordati Industria Chimica e Farmaceutica SPA’s PEG ratio is 0.96.

PE Ratio

21.81

PS Ratio

4.01

PB Ratio

5.06

Price to FCF

18.66

Price to Operating Cash Flow

16.72

PEG Ratio

0.96

In the last 12 months, Recordati Industria Chimica e Farmaceutica SPA had revenue of 2.62B and earned 443.62M in profits. Earnings per share was 2.16.

Revenue

2.62B

Gross Profit

1.79B

Operating Income

719.74M

Pretax Income

581.27M

Net Income

443.62M

EBITDA

887.00M

Earnings Per Share (EPS)

2.16

In the last 12 months, operating cash flow was 644.69M and capital expenditures -62.85M, giving a free cash flow of 581.83M billion.

Operating Cash Flow

644.69M

Free Cash Flow

581.83M

Free Cash Flow per Share

2.86

Recordati Industria Chimica e Farmaceutica SPA pays an annual dividend of ―, resulting in a dividend yield of 2.42%

Dividend Per Share

―

Dividend Yield

2.42%

Payout Ratio

N/A

Free Cash Flow Yield

5.36%

Earnings Yield

4.61%

Beta

0.11

52-Week Price Change

-6.68%

50-Day Moving Average

1030.41

200-Day Moving Average

1030.98

Relative Strength Index (RSI)

99.98

Average Volume (3m)

2,880

Recordati Industria Chimica e Farmaceutica SPA upcoming earnings date is Nov 10, 2026, TBA (Not Confirmed).

Last Earnings Date

Jul 28, 2026

Next Earnings Date

Nov 10, 2026

Ex-Dividend Date

―

Recordati Industria Chimica e Farmaceutica SPA as a current ratio of 1.59, with Debt / Equity ratio of 128.53%

Current Ratio

1.59

Quick Ratio

1.08

Debt to Market Cap

0.24

Net Debt to EBITDA

2.30

Interest Coverage Ratio

7.25

In the past 12 months, Recordati Industria Chimica e Farmaceutica SPA has paid 137.65M in taxes.

Income Tax

137.65M

Effective Tax Rate

0.24

Recordati Industria Chimica e Farmaceutica SPA EV to EBITDA ratio is 12.89, with an EV/FCF ratio of 21.95.

EV to Sales

4.72

EV to EBITDA

12.89

EV to Free Cash Flow

21.95

EV to Operating Cash Flow

19.81

Recordati Industria Chimica e Farmaceutica SPA has MXN 391.38M in cash and marketable securities with MXN 2.31B in debt, giving a net cash position of -MXN 1.92B billion.

Cash & Marketable Securities

MXN 391.38M

Total Debt

MXN 2.31B

Net Cash

-MXN 1.92B

Net Cash Per Share

-MXN 9.17

Tangible Book Value Per Share

-MXN 5.29

Gross margin is 70.74%, with operating margin of 30.46%, and net profit margin of 18.38%.

Gross Margin

70.74%

Operating Margin

30.46%

Pretax Margin

24.35%

Net Profit Margin

18.38%

EBITDA Margin

36.63%

EBIT Margin

28.86%

The average price target for Recordati Industria Chimica e Farmaceutica SPA is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

9.10%

EPS Growth Forecast

22.99%